Alessandro Riva, M.D.

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Bicycle Therapeutics PLC publishes a filing, an earnings call transcript or a press release.

Get BCYC alerts

About Alessandro Riva, M.D.

Alessandro Riva, M.D. is recorded as Board Member at Bicycle Therapeutics PLC (BCYC) since March 25, 2025. Bicycle Therapeutics PLC reported in an 8-K filed March 27, 2025 that Alessandro Riva, M.D. was appointed Class III director (member of the Board and the Scientific Committee), effective March 25, 2025. Bicycle Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Bicycle Therapeutics PLC includes Kevin Lee (CEO and Board Member), Felix J. Baker, Ph.D. (Chairman and Board Member), Pierre Legault (Chairman) and 7 others.

“On March 23, 2025, the Board of Directors (the "Board") of Bicycle Therapeutics plc (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Alessandro Riva, M.D., to the Board and the Scientific Committee of the Board, effective as of the close of business on March 25, 2025, New York City time.”

Bicycle Therapeutics PLC Form 8-K, filed March 27, 2025 · Read the filing

Affiliation history

Bicycle Therapeutics PLC (BCYC)
Board Member

SEC 8-K

Current
2025-03-25–present

Company network

Bicycle Therapeutics PLC

BCYC

Current role

Biotechnology · Healthcare

Board Member

2025-03-25–present

Leadership on record at Bicycle Therapeutics PLC

Kevin Lee CEO, Board Member
Felix J. Baker, Ph.D. Chairman, Board Member
Pierre Legault Chairman
Alethia Young CFO
Travis Thompson CFO, Chief Accounting Officer
Alistair Milnes COO
Jennifer Perry COO
Jennifer Perry, Pharm.D. COO
Michael Skynner COO, CTO
Bosun Hau Board Member

Recent activity

Executive change Appointed: Class III director (member of the Board and the Scientific Committee) Bicycle Therapeutics PLC (BCYC)
2025-03-25